ADORA2A and metastatic melanoma: A2AR stimulation has direct myelosuppressive effects that indirectly contribute to suppression of T cells and NK cells in primary and metastatic melanoma microenvironments, indicating that the blocking of the A2AR has the potential to enhance immune killing of tumors [103,104].